Abstract |
Prostate cancer exhibits a lineage-specific dependence on androgen signaling. Castration resistance involves reactivation of androgen signaling or activation of alternative lineage programs to bypass androgen requirement. We describe an aberrant gastrointestinal-lineage transcriptome expressed in ∼5% of primary prostate cancer that is characterized by abbreviated response to androgen-deprivation therapy and in ∼30% of castration-resistant prostate cancer. This program is governed by a transcriptional circuit consisting of HNF4G and HNF1A. Cistrome and chromatin analyses revealed that HNF4G is a pioneer factor that generates and maintains enhancer landscape at gastrointestinal-lineage genes, independent of androgen-receptor signaling. In HNF4G/HNF1A-double-negative prostate cancer, exogenous expression of HNF4G at physiologic levels recapitulates the gastrointestinal transcriptome, chromatin landscape, and leads to relative castration resistance.
|
Authors | Shipra Shukla, Joanna Cyrta, Devan A Murphy, Edward G Walczak, Leili Ran, Praveen Agrawal, Yuanyuan Xie, Yuedan Chen, Shangqian Wang, Yu Zhan, Dan Li, Elissa W P Wong, Andrea Sboner, Himisha Beltran, Juan Miguel Mosquera, Jessica Sher, Zhen Cao, John Wongvipat, Richard P Koche, Anuradha Gopalan, Deyou Zheng, Mark A Rubin, Howard I Scher, Ping Chi, Yu Chen |
Journal | Cancer cell
(Cancer Cell)
Vol. 32
Issue 6
Pg. 792-806.e7
(Dec 11 2017)
ISSN: 1878-3686 [Electronic] United States |
PMID | 29153843
(Publication Type: Journal Article)
|
Copyright | Copyright © 2017 Elsevier Inc. All rights reserved. |
Chemical References |
- HNF1A protein, human
- HNF4G protein, human
- Hepatocyte Nuclear Factor 1-alpha
- Hepatocyte Nuclear Factor 4
- SPINK1 protein, human
- Trypsin Inhibitor, Kazal Pancreatic
|
Topics |
- Animals
- Drug Resistance, Neoplasm
(physiology)
- Gene Expression Regulation, Neoplastic
(physiology)
- Hepatocyte Nuclear Factor 1-alpha
(metabolism)
- Hepatocyte Nuclear Factor 4
(metabolism)
- Heterografts
- Humans
- Male
- Mice
- Mice, SCID
- Prostatic Neoplasms, Castration-Resistant
(metabolism, pathology)
- Trypsin Inhibitor, Kazal Pancreatic
(biosynthesis)
|